When

Monday November 2, 2015 from 1:00 PM to 2:00 PM EST
Add to Calendar 

Where

NIH Natcher Conference Center, 
Building 45, Room F1/F2
Bethesda, MD
 

 
Driving Directions 

Contact

Mary Ann Anderson-Garlic 
Office of Behavioral and Social Sciences Research (OBSSR) 
301-451-3765 
maryann.anderson-garlic@nih.gov 
NIH Adherence Network Distinguished Speaker Webinar Series

02
Nov
Title:  Minimally Disruptive Medicine and its implications for improving patient adherence
Date:  Monday, November 2, 2015
Time:  1:00 pm – 2:00 pm EDT
Presenter:  Dr. Victor Montori, Professor of Medicine, Mayo Clinic
Sponsor:  NIH Office of Behavioral Health and Social Sciences (OBSSR)
Location: 

Natcher Conference Center,
Building 45, Room F1/F2
National Institutes of Health Campus
Bethesda, MD

LIVE WEBCAST

Abstract

Adherence to medical interventions requires patient work, work that many patients cannot enact. Minimally disruptive medicine seeks to advance patient goals for life and care while reducing the healthcare footprint on patient lives. In this discussion, we will review how these ideas could transform clinical care and consider some derived tools and interventions.

Objectives

At the end of this activity, participants should be able to:

  • Explain how to replace “noncompliance” for workload to capacity imbalance to orient the organization and delivery of care.
  • Describe the use of the Cumulative Complexity Model to orient the evaluation of new healthcare initiatives.
  • Identify actions in the clinic and at the system level that could help manage the workload to capacity imbalance.

Presenter’s Bio 

Victor M. Montori, MD is a Professor of Medicine at Mayo Clinic. An endocrinologist and health services researcher, Dr. Montori is the author of more than 500 peer-reviewed publications and editor of 2 books of evidence-based endocrinology. In 2014 and again in 2015, he was recognized as among the top 1% of researchers with most cited papers in clinical medicine worldwide in the last decade. He is member of the National Advisory Council of the Agency for Healthcare Research and Quality, the Editorial Advisory Board for the BMJ, and Director of Late Stage Translational Research at the Mayo Center for Clinical and Translational Science. He is a recognized expert in evidence-based medicine and shared decision making, and developer of the concept of minimally disruptive medicine. He works in Rochester, Minnesota, at Mayo Clinic's KER Unit, to advance person-centered care for patients with diabetes and other chronic conditions.